AMENDMENT NO. 2 TOConsulting Agreement • February 25th, 2021 • Voyager Therapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 25th, 2021 Company IndustryThis Amendment No. 02 TO CONSULTING AGREEMENT (“Amendment”) is entered into as of August 1, 2020 (the “Amendment Effective Date”) between Steven M. Paul, M.D. (“Company”) and Voyager Therapeutics, Inc. (“Voyager”) and relates to the Agreement referred to below.